Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Net Loans Change in Receivables Change in Receivables Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Preferred Shares Issued Preferred Shares Repurchased Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Fortress Biotech (FBIO) Amortizatization of Intangibles (2016 - 2025)

Fortress Biotech has reported Amortizatization of Intangibles over the past 11 years, most recently at $2.8 million for Q4 2025.

Quarterly results put Amortizatization of Intangibles at $2.8 million for Q4 2025, up 184.51% from a year ago — trailing twelve months through Dec 2025 was $6.0 million (up 74.82% YoY), and the annual figure for FY2025 was $4.3 million, up 24.36%.
Amortizatization of Intangibles for Q4 2025 was $2.8 million at Fortress Biotech, up from $1.1 million in the prior quarter.
Over the last five years, Amortizatization of Intangibles for FBIO hit a ceiling of $2.8 million in Q4 2025 and a floor of $200000.0 in Q2 2021.
Median Amortizatization of Intangibles over the past 5 years was $897500.0 (2024), compared with a mean of $1.0 million.
Peak annual rise in Amortizatization of Intangibles hit 400.0% in 2022, while the deepest fall reached 76.34% in 2022.
Fortress Biotech's Amortizatization of Intangibles stood at $2.3 million in 2021, then plummeted by 76.34% to $542000.0 in 2022, then surged by 171.4% to $1.5 million in 2023, then crashed by 33.31% to $981000.0 in 2024, then soared by 184.51% to $2.8 million in 2025.
The last three reported values for Amortizatization of Intangibles were $2.8 million (Q4 2025), $1.1 million (Q3 2025), and $1.1 million (Q2 2025) per Business Quant data.